RE: Final results24 Apr 2026 08:50
Maybe true...it could recover, but with the way the current trading reads, it doesn't look like it will happen too soon.
"The Company expects to publish its audited full year results for the financial year ended 30 November 2025 ("FY25") in April 2026. During FY25, the Group continued to execute its growth strategy. Despite a challenging trading environment, the Group delivered total unaudited revenue of £8.6 million (FY24: £12.0 million), with an unaudited operating loss of £0.6 million (FY24: operating profit of £0.3 million). The CEM division contributed £6.3 million of revenue (FY24: £9.5 million) and £0.4 million of operating profit (FY24: £0.6 million), the AGT division £1.0 million of revenue (FY24: £0.8 million) and £0.3 million of operating loss (FY24: £0.5 million operating loss), and the PFP division £1.4 million of revenue (FY24: £1.8 million) and £0.3 million of operating profit (FY24: £0.6 million).
The Group's year-on-year revenue decreased, primarily reflecting lower sales from a key CEM division customer. Recovery in CEM has focused on securing defence and medical accreditations, while the PFP division pipeline is awaiting BSR approvals, which have been moved from the Health and Safety Executive to the Ministry of Housing, Communities and Local Government. The Group gross margin is uplifted, supported by strong margin contributions from the PFP and AGT divisions, with CEM targeting higher-margin defence and medical revenues. The Group's cash position at 30 November 2025 stood at £0.7 million (30 November 2024: £1.2 million), with fully utilised working capital facilities (FY24: £0.7 million). The 2026 financial year is expected to be cash generative for the Group."